Merlin Ventures Ltd.
This article was originally published in Start Up
Executive Summary
The UK boasts the world's second largest biotech industry, despite the historical lack of seed capital for scientists that want to found companies with promising technologies. Although a handful of VC firms do early stage investing on a small scale, Merlin feels it is unique because it funds companies that don't even have a business plan yet. The firm has raised a $60 million fund and hopes to have created 10-12 companies by year end.